五子散辅助治疗风痰阻络型脑梗死偏瘫的临床疗效

Clinical observation of Wuzi powder in the treatment of cerebral infarction hemiplegia with wind phlegm obstructing collaterals

目的:探讨五子散辅助治疗风痰阻络型脑梗死偏瘫的临床疗效。方法:回顾性分析2018年12月—2020年6月我院收治的60例风痰阻络型脑梗死偏瘫患者资料,随机分为两组(观察组、对照组),每组30例。以常规西药施治对照组;在此基础上,以中药复方五子散封包对观察组进行辅助治疗。两组治疗周期均为1周,治疗结束后评定临床疗效,并通过比较两组治疗前后FMA评分评价肢体功能恢复情况。结果:治疗前,两组FMA评分均不高,且分值接近,组间比较差异无统计学意义(P>0.05);治疗后,两组FMA评分均较治疗前有所升高,但升高幅度有异,观察组升高幅度较大,与同期对照组比较,差异具有统计学意义(P<0.05)。临床总有效率观察组90.00%(27/30),对照组76.67%(23/30),差异具有统计学意义(P<0.05)。结论:五子散辅助治疗风痰阻络型脑梗死偏瘫的临床疗效显著,可有效改善偏瘫患者的肢体功能及预后。

Objective:To analyze the clinical efficacy of Wuzi powder in the treatment of cerebral infarction hemiplegia with wind phlegm obstructing collaterals.Methods:60 cases of cerebral infarction hemiplegia with phlegm obstruction were divided into observation group and control group,30 cases in each group.The patients in the control group were treated with conventional medicine,and the patients in the observation group were treated with traditional Chinese medicine Wuzi powder.The treatment cycle of the two groups was 2 weeks.After the treatment,the clinical efficacy and the FMA motor function scale score were evaluated in the two groups.Results:Before treatment,the difference in FMA scores between the two groups was not statistically significant(P>0.05);after treatment,the FMA scores of the two groups were increased in varying degrees,especially in the observation group,which was significantly different from the control group at the same period(P<0.05).The clinical total effective rate was 90.00%(27/30)in the observation group and 76.67%(23/30)in the control group,there was significant difference in clinical efficacy between the two groups(P<0.05).Conclusion:Wuzi powder is effective in the treatment of cerebral infarction hemiplegia with wind phlegm obstructing collaterals,which can effectively improve the limb function and prognosis of patients with hemiplegia.